1-4 of 4
Tetsuyuki Kiyokawa
Close
Sort by
Journal Articles

Prognostic Factors Associated with Outcomes of RIC and MAC Hematopoietic Stem Cell Transplantation: An Indication for the Selection of Conditioning

Tetsuyuki Kiyokawa, Shoichi Nagakura, Michihiro Hidaka, Takahiro Yano, MD, Kazutaka Sunami, MD, PhD, Seiichi Okamura, Naokuni Uike, Motohiro Hamaguchi, Takahiro Matsui, Keizo Horibe, MD, Kensaku Sato, Toshiro Kawakita, Fumio Kawano
Journal: Blood
Blood (2008) 112 (11): 4402.
https://doi.org/10.1182/blood.V112.11.4402.4402
Published: 2008
Journal Articles

Risk Factors Associated with VOD with RIC and MAC Hematopoietic Stem Cell Transplant and the Early Estimation of VOD

Shoichi Nagakura, Tetsuyuki Kiyokawa, Michihiro Hidaka, Takahiro Yano, MD, Kazutaka Sunami, MD, PhD, Seiichi Okamura, Naokuni Uike, Motohiro Hamaguchi, Takahiro Matsui, Keizo Horibe, MD, Kensaku Sato, Toshiro Kawakita, Fumio Kawano
Journal: Blood
Blood (2008) 112 (11): 4315.
https://doi.org/10.1182/blood.V112.11.4315.4315
Published: 2008
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

Shigeki Takemoto, MD, Michihiro Hidaka, MD, Shoichi Nagakura, MD, Tatsunori Sakai, MD, Takahiro Matsui, MD, Toshiro Kawakita, MD, Yoshiko Inoue, MD, Atsuko Tsukamoto, MD, Tetsuyuki Kiyokawa, MD, Fumio Kawano, MD
Journal: Blood
Blood (2007) 110 (11): 5037.
https://doi.org/10.1182/blood.V110.11.5037.5037
Published: 2007
Journal Articles

Number of Prior Chemotherapy Regimens: Important Prognositic Factor of All-Cause Mortality after Allogeneic Hematopoietic Cell Transplantation.

Tetsuyuki Kiyokawa, MD, Shoichi Nagakura, MD, Michihiro Hidaka, MD, Naokuni Uike, MD, Motohiro Hamaguchi, MD, Keizo Horibe, MD, Kensaku Sato, Humio Kawano, MD
Journal: Blood
Blood (2007) 110 (11): 1104.
https://doi.org/10.1182/blood.V110.11.1104.1104
Published: 2007